Interaction of human intestinal and hepatoma alkaline phosphatases with immobilized cibacron blue F3GA

Interaction of human intestinal and hepatoma alkaline phosphatases with immobilized cibacron blue F3GA

Vo1.111, No, 1,1983 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Pages 36-40 February 28, 1983 INTERACTION OF HUMAN INTESTINAL AND HEPATOMA ...

243KB Sizes 0 Downloads 26 Views

Vo1.111, No, 1,1983

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Pages 36-40

February 28, 1983

INTERACTION OF HUMAN INTESTINAL AND HEPATOMA ALKALINE PHOSPHATASES WITH IMMOBILIZED CIBACRON BLUE F3GA Hideo Yamamoto, Masanobu Tanaka, Toshikazu Okochi, and Susumu Kishimoto Third Department of Internal Medicine, Osaka University School of Medicine, Fukushima, Osaka 553, Japan Received December 23, 1982

SUMMARY: Possible interactions of human liver and intestinal alkaline phosphatases with Cibacron Blue F3GA were examined. The results indicated that the intestinal enzyme bound to the dye column whereas the liver enzyme did not. The affinity of intestinal alkaline phosphatase with the dye-ligand appeared to be biospecific, since a low concentration of purine nueleoside phosphates or potassium phosphate specifically reversed the binding. Taking advantage of the variant alkaline phosphatase from human hepatocellular cancer tissue to behave on the dye adsorbent in a similar fashion with the intestinal enzyme, it was purified by Cibacron Blue F3GA affinity chromatography, producing a 189fold purification with a yield of 93%.

A sulfonated polyaromatic blue dye, called Cibacron Blue F3GA, complexes with a wide range of proteins with the dinucleotide fold (i).

This structure

is known to form NAD, ATP and other nucleotides binding sites in a variety of enzymes such as lactate dehydrogenase (EC 2.7.2.3).

(EC 1.1.1.27) and phosphoglycerate kinase

The emergence of immobilized Cibacron Blue F3GA as a general

ligand for affinity chromatography has led to new and improved techniques for the purification of enzymes with the dinucleotide fold. Although alkaline phosphatases

(EC 3.1.3.1) from various sources are

designated under one name, they differ in their physical and kinetic character, as well as in their response to activators and inhibitors

(2).

Eaton and Moss

have demonstrated that although the mono-, di- and triphosphates of adenosine or uridine were all active substrates of human liver and small intestinal alkaline phosphatases,

the intestinal enzyme showed greater organic phosphatase

activity relative to its orthophosphatase activity than did the liver enzyme (3). In view of their data, we decided to examine possible interactions of tl~ese two enzymes with Cibaeron Blue FBGA affinity columns.

0006-291X/83/040036-05501.50/0 Copyright © 1983byAcademic Press, ~c. Affrigh~ofreproduet~n ~ anyform rese~ed.

36

The results indicated

Vol. 111, No. 1, 1983

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

that the intestinal enzyme specifically under certain conditions whereas of the dye-ligand

bound to and eluted from the dye column

the liver enzyme did not bind.

affinity chromatography

fied in its application

The potency

as a purification method was exempli-

to the variant alkaline phosphatase

Warnock and Reisman in human hepatocellular

cancer

first observed by

(4).

MATERIALS AND METHODS B-NAD, ATP, ADP, AMP, adenosine, GTP, GDP, GMP, guanosine were obtained from Sigma as the sodium salts. L-Phenylalanine and L-tryptophan were from Wako Pure Chemical Industries. Affi-Gel Blue (100-200 mesh) was purchased from Bio-Rad Laboratories. Alkaline phosphatase was assayed in 2 ml of 0.i M carbonate-bicarbonate buffer, pH I0.0, containing i0 mM disodium phenyl phosphate, 3 mM 4-aminoantipyirne, 1 mM MgCI2 and enzyme. The reaction was started by the addition of enzyme. After incubation for 15 min at 37°C, it was terminated by the addition of 2 ml 65 mM acetic acid containing 36 m M potassium ferricyanide. The liberated phenol was determined by measuring the absorbance at 500 nm. One unit was defined as the activity that liberates one umol of phenol per min under the conditions employed. Protein concentration was determined by the method of Lowry et al. (5). Human liver, small intestines and hepatocellular cancer tissue were obtained from autopsy and stored at -70°C until used. The alkaline phosphatases from these sources were partially purified by butanol extraction, acetone precipitation, ammonium sulfate precipitation, DEAE-cellulose chromatography and Sephadex G-200 gel filtration according to the modified method of Moss et al. (6). The specific activities of the enzyme preparations were 43.1 and 117 units per mg protein for the normal liver and intestinal enzymes, respectively. The variant alkaline phosphatase preparation from DEAE-cellulose chromatography, which had a specific activity of 1.90 units per mg protien, was extensively dialyzed against i0 mM Tris-HCl buffer, pH 7.5, and applied to an Affi-Gel Blue column.

RESULTS The purified human liver alkaline phosphatase was applied to an Affi-Gel Blue column with i0 mM Tris-HCl buffer, approximately appeared

(3 units,

69.6 pg protein)

(1.3 x 7.5 cm), previously equilibrated

pH 7.5, at a flow rate of 2.5 ml per hr.

However,

total activity of the enzyme failed to bind to the column and

in the void volume.

The purified

intestinal

The result was confirmed by using a larger column. alkaline phosphatase

was applied to the same column 40 ml of the equilibration

(3 units, 25.6 ~g protein)

(1.3 × 7.5 cm), and the column was washed with

buffer.

In contrast

to the liver enzyme, nearly

total activity of the intestinal enzyme was retained to the column.

3?

The effect

VOI. 111, No. 1, 1983

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Table i.

Effect of eluting agents tested

Elutin$ asent tested

Concentration

NAD ATP, ADP, AMP GTP, GDP, GMP adenosine, guanosine potassium phosphate L-phenylalanine, L-tryptophan Tris-IICI, pH 7.5 Tris-HCI, pH 7.5

(mM)

Elution

i 1 i i 1 5 50 i00

No Yes Yes No Yes No No Yes

A series of Affi-Gel Blue columns (1.3 X 7.5 cm) were equilibrated with i0 mM Tris-HCl buffer, pH 7.5. The intestinal alkaline phosphatase preparation (3 units, 25.6 Dg protein) was applied to each of the columns at a flow rate of 2.5 ml per hr. After the column was washed with 40 ml of the equilibration buffer, the enzyme was eluted by the addition of indicated concentrations of each eluting agent to the same buffer. A total of 40 ml eluate was collected in 2-ml fractions.

of the tested

eluting

or triphosphates phosphate readily

agents

of adenosine

in i0 m M Tris-HCI,

eluted

each case.

in a single

A pulse

representing

phosphates

stereospecific

were not effective

' Cibacron

of the variant

tissue.

The enzyme

column

(1.6 X i0 cm),

and recycled

to assure

level

as a ligand

equilibrated

adenosine

nor

L-Phenylalanine alkaline

phos-

for the c h r o m a t o g r a p h i c

puri-

intestinal

from human h e p a t o c e l l u l a r was applied with

cancer

to an A f f i - G e l

i0 m M Tris-HCI

of the enzyme

with 60 ml of the e q u i l i b r a t i o n

phosphate

containing

buffer,

Blue pH

for 24 hr at a flow rate of I0 ml per hr

of binding

off the column,

in

very gradually,

Neither

the enzyme.

100%

either.

phosphatase

the column

the enzyme

phosphate.

of human

20 mg protein)

previously

through

peak eluted

1 mM p o t a s s i u m

alkaline

agents

the enzyme

than i0 m M Tris-HCl

to eluate

inhibitors

eluting

(38 units,

an increased

column was washed protein

or p o t a s s i u m

agent,

di-

of potassium

was approximately

pH 7.5 eluted

less effective

Blue F3GA was examined

fication

7.5,

was

When i m M mono-,

as an eluting

The recovery

nor NAD at 1 m M was not able

and L-tryptophan, phatase,

peak.

i.

or the same c o n c e n t r a t i o n

pH 7.5 was used

sharp

i00 mM Tris-HCl

in Table

or guanosine,

of I00 m M Tris-HCI,

1 r~i purine nucleoside guanosine

is summarized

the enzyme was

to the same buffer

38

activity

buffer.

applied.

After

the initial

eluted by the a d d i t i o n

(Fig.l).

The

The

specific

of

activity

of

Vol. 111, No. 1, 1983

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNI£ATIONS

20

I mM potassium ~ phosphate

IJJ

O3 < "r'o n r-

1.0

0 "r~ I0 13_...

._I ,<~

',

5

o.s

i

J

"--"-" . . . . . . . . . .

":

--

""

I0 20 FRACTION NUMBER

0

0

30

Fig. I. Elution profile of variant alkaline phosphatase from Affi-Gel Blue. An Affi-Gel Blue column (1.6× l0 cm) was equilibrated with i0 mM TrisHCI buffer, pIl 7.5. The enzyme preparation (38 units, 20 mg protein) was applied to the column, and recycled through the column for 24 hr at a flow rate of i0 ml per hr. The column was then washed with 60 ml of the equilibration buffer, and the enzyme was eluted with i mM potassium phosphate in the same buffer at a flow rate of 4 ml per hr. 4-ml fractions were collected. Dotted line, absorbance at 280 nm; solid circles, enzyme in units/fraction.

the enzyme 189-fold

eluted

from the column was

purification

with a yield

359 units

per mg protein,

representing

a

of 93%.

DISCUSSION We have

studied

three human

hepatocellular

cancer

tissue,

hepatoblastoma

tissue

(7).

immunologically degree, tical,

suggesting although

tibility finding bound

identical that

and HUH-6,

These

three

and inhibited

to neuraminidase

phosphatases a cultured

alkaline

in m o l e c u l a r

isoenzymes

phosphatases

weight,

Blue F3GA affinity

amino

The most

column

proved acids

interesting

type alkaline

whereas

liver

from

to be

to an equal

sites must be iden-

thermostability

of intestinal

intestine,

cell line e s t a b l i s h e d

of their catalylic

(data not shown).

that all of these

from small

by the various

the a r c h i t e c t u r e

they differed

to a Cibacron

alkaline

and suscepresult

is the

phosphatase

alkaline

phosphatase

did not. The precise phosphatases appear

mechanism

for the i n t e r a c t i o n s

w i t h the dye cannot

to be biospecific

be fully

in nature

and not

39

of the intestinal

explained. ionic,

However,

since

type alkaline

these interactions

the ionic

strength

of

Vol. 111, No. 1, 1983

Tris-NCl required

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

to eluate the enzymes was much higher than the ionic strength

of purine nucleoside phosphates or potassium phosphate required for elution. In addition,

ionic interactions between these acidic glycoproteins

anionic dye are unlikely to occur. interactions

Furthermore,

that the dye-enzyme complexes

of salt, and broken in high concentrations

and the

it indicates non-hydrophobic

could be formed in low concentrations of salt, since hydrophobic

inter-

actions are generally more intense at higher salt concentrations. Bouriotis

and Dean have examined Cibacron Blue 3GA-Sepharose

graphy as a method for the purification tine (8). extract,

of alkaline phosphatase

6B chromato-

from calf intes-

They obtained a 17-, 128- or 290-fold purification over the initial using gradients of potassium chloride or pulsed elution with i0 mM

inorganic phosphate or the same concentration enzyme protein, chromatography

respectively.

of ~-naphthyl

They have concluded

phosphate to desorb

that the dye-ligand

affinity

coupled with the use of affinity elution would provide a useful

purification method for alkaline phosphatase

from calf intestine extracts.

Our

present preliminary data have also shown that Cibacron Blue F3GA affinity chromatography will be a useful method for the purification human intestinal type alkaline phosphatase. phosphatases

of various isoenzymes

The variant and liver alkaline

often coexist in sera or cancer tissues of patients with hepato-

cellular cancer.

This dye-ligand affinity chromatography will be particularly

useful in separating

the former enzyme from the latter.

REFERENCES i. 2. 3. 4. 5. 6. 7. 8.

Sundaram, P.V., and Eckstein, F. (1978) Theory and Practice in Affinity Techniques, pp. 23-44, Academic Press, New York. Fishman, W.H. (1974) Am. J. Med. 56, 617-650. Eaton, R.H., and Moss, D.W. (1967) Biochem. J. 105, 1307-1312. Warnock, M.L., and Reisman, R. (1969) Clin. Chim. Acta. 24, 5-11. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951) J. Biol. Chem. 193, 265-275. Moss, D.W., Eaton, R.H., Smith, J.K., and Whitby, L.G. (1967) Biochem. J. 102, 53-57. Doi, I. (1976) Gann. 67, i-i0. Bouriotis, V., and Dean, P.D.G. (1981) J. Chromatogr. 206, 521-530.

40

of